A detailed history of Marshall Wace, LLP transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 48,987 shares of MORF stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,987
Previous 336,518 85.44%
Holding current value
$1.67 Million
Previous $9.72 Million 82.26%
% of portfolio
0.0%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$26.64 - $40.31 $7.66 Million - $11.6 Million
-287,531 Reduced 85.44%
48,987 $1.72 Million
Q4 2023

Feb 14, 2024

BUY
$19.95 - $31.0 $5.82 Million - $9.05 Million
291,871 Added 653.73%
336,518 $9.72 Million
Q3 2023

Nov 14, 2023

SELL
$21.33 - $59.42 $760,819 - $2.12 Million
-35,669 Reduced 44.41%
44,647 $1.02 Million
Q2 2023

Aug 14, 2023

SELL
$34.33 - $62.11 $256,925 - $464,831
-7,484 Reduced 8.52%
80,316 $4.6 Million
Q1 2023

May 15, 2023

SELL
$26.01 - $48.69 $13.6 Million - $25.5 Million
-523,776 Reduced 85.64%
87,800 $3.3 Million
Q4 2022

Feb 14, 2023

SELL
$24.14 - $30.37 $2.55 Million - $3.2 Million
-105,464 Reduced 14.71%
611,576 $16.4 Million
Q3 2022

Nov 14, 2022

SELL
$22.23 - $33.37 $2 Million - $3 Million
-89,956 Reduced 11.15%
717,040 $20.3 Million
Q2 2022

Aug 15, 2022

BUY
$19.74 - $43.01 $4.1 Million - $8.94 Million
207,885 Added 34.7%
806,996 $17.5 Million
Q1 2022

May 16, 2022

SELL
$36.25 - $52.02 $2.21 Million - $3.17 Million
-60,873 Reduced 9.22%
599,111 $24.1 Million
Q4 2021

Feb 14, 2022

BUY
$43.27 - $65.72 $27.7 Million - $42.1 Million
640,847 Added 3348.73%
659,984 $31.3 Million
Q3 2021

Nov 15, 2021

SELL
$53.61 - $67.5 $5.23 Million - $6.59 Million
-97,565 Reduced 83.6%
19,137 $1.08 Million
Q2 2021

Aug 13, 2021

SELL
$45.13 - $64.99 $10.8 Million - $15.5 Million
-238,976 Reduced 67.19%
116,702 $6.7 Million
Q1 2021

May 17, 2021

BUY
$29.77 - $84.85 $10.6 Million - $30.2 Million
355,678 New
355,678 $22.5 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.